These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 18262334)

  • 1. More nomograms or better evidence of efficacy: what do we need in urologic oncology?
    Catto JW
    Eur Urol; 2008 Jul; 54(1):11-2. PubMed ID: 18262334
    [No Abstract]   [Full Text] [Related]  

  • 2. Rebuttal from authors re: James W.F. Catto. More nomograms or better evidence of efficacy: what do we need in urologic oncology? Eur Urol 2008;54:11-12.
    Shariat SF; Margulis V; Karakiewicz PI
    Eur Urol; 2008 Jul; 54(1):13-5. PubMed ID: 18329787
    [No Abstract]   [Full Text] [Related]  

  • 3. Nomograms for prostate cancer.
    Stephenson AJ; Kattan MW
    BJU Int; 2006 Jul; 98(1):39-46. PubMed ID: 16831140
    [No Abstract]   [Full Text] [Related]  

  • 4. Do we need more nomograms for predicting outcomes in patients with prostate cancer?
    Kattan MW
    Nat Clin Pract Urol; 2008 Jul; 5(7):366-7. PubMed ID: 18506152
    [No Abstract]   [Full Text] [Related]  

  • 5. How often do available preoperative risk factors accurately predict the risk assessed after surgery for localized prostate cancer?
    Laudano MA; Lambert SM; Masson P; McCann TR; Desai M; Benson MC; McKiernan JM
    BJU Int; 2009 Feb; 103(3):317-20. PubMed ID: 18778341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging in the prediction of biochemical recurrence of prostate cancer after radical prostatectomy.
    Fuchsjäger MH; Shukla-Dave A; Hricak H; Wang L; Touijer K; Donohue JF; Eastham JA; Kattan MW
    BJU Int; 2009 Aug; 104(3):315-20. PubMed ID: 19220263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive significance of surgical margin status after prostatectomy for prostate cancer during PSA era.
    Mann MJ; DeCastro GJ; Desai M; Benson MC; McKiernan JM
    Urology; 2008 Dec; 72(6):1203-7. PubMed ID: 18674807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. External validation of a biomarker-based preoperative nomogram predicts biochemical recurrence after radical prostatectomy.
    Shariat SF; Walz J; Roehrborn CG; Zlotta AR; Perrotte P; Suardi N; Saad F; Karakiewicz PI
    J Clin Oncol; 2008 Mar; 26(9):1526-31. PubMed ID: 18349404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment prostate-specific antigen velocity and the risk of death from prostate cancer in the individual with low-risk prostate cancer.
    D'Amico AV; Chen MH
    J Clin Oncol; 2009 Aug; 27(22):3575-6. PubMed ID: 19506151
    [No Abstract]   [Full Text] [Related]  

  • 10. A nomogram predicting long-term biochemical recurrence after radical prostatectomy.
    Suardi N; Porter CR; Reuther AM; Walz J; Kodama K; Gibbons RP; Correa R; Montorsi F; Graefen M; Huland H; Klein EA; Karakiewicz PI
    Cancer; 2008 Mar; 112(6):1254-63. PubMed ID: 18286530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The current state of brachytherapy nomograms for patients with clinically localized prostate cancer.
    Nguyen CT; Zelefsky MJ; Kattan MW
    Cancer; 2009 Jul; 115(13 Suppl):3121-7. PubMed ID: 19544540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial comment on: Risk-adjusted hazard rates of biochemical recurrence for prostate cancer patients after radical prostatectomy.
    Hakenberg OW
    Eur Urol; 2009 Feb; 55(2):421. PubMed ID: 19027224
    [No Abstract]   [Full Text] [Related]  

  • 13. Cross-cultural validation of a prognostic tool: example of the Kattan preoperative nomogram as a predictor of prostate cancer recurrence after radical prostatectomy.
    Rouprêt M; Hupertan V; Comperat E; Drouin SJ; Phé V; Xylinas E; Demanse D; Sibony M; Richard F; Cussenot O
    BJU Int; 2009 Sep; 104(6):813-7; discussion 817-8. PubMed ID: 19254280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nomograms are more meaningful than severity-adjusted institutional comparisons for reporting outcomes.
    Hixson ED; Kattan MW
    Eur Urol; 2006 Apr; 49(4):600-3. PubMed ID: 16439054
    [No Abstract]   [Full Text] [Related]  

  • 15. An updated catalog of prostate cancer predictive tools.
    Shariat SF; Karakiewicz PI; Roehrborn CG; Kattan MW
    Cancer; 2008 Dec; 113(11):3075-99. PubMed ID: 18823041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial comment on: Predictive value of the differential expression of the urokinase plasminogen activation axis in radical prostatectomy patients.
    van der Poel HG
    Eur Urol; 2009 May; 55(5):1133-4. PubMed ID: 18585847
    [No Abstract]   [Full Text] [Related]  

  • 17. Prediction of cancer relapse after prostatectomy: use the postoperative nomogram.
    Fromont G
    Clin Cancer Res; 2009 Jan; 15(1):413; author reply 413-4. PubMed ID: 19118074
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorial comment on: Predictive value of the differential expression of the urokinase plasminogen activation axis in radical prostatectomy patients.
    Berney DM
    Eur Urol; 2009 May; 55(5):1134. PubMed ID: 18585844
    [No Abstract]   [Full Text] [Related]  

  • 19. Predicting the risk of recurrence after surgery for prostate cancer.
    Ebell MH
    Am Fam Physician; 2005 Dec; 72(12):2511-2. PubMed ID: 16370408
    [No Abstract]   [Full Text] [Related]  

  • 20. Inventory of prostate cancer predictive tools.
    Shariat SF; Karakiewicz PI; Margulis V; Kattan MW
    Curr Opin Urol; 2008 May; 18(3):279-96. PubMed ID: 18382238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.